{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:51:55Z","timestamp":1781614315969,"version":"3.54.5"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sugammadex, a neuromuscular blockade reversal agent, has a reported incidence of severe anaphylaxis of approximately 0.005% in Japan, typically occurring within 5\u00a0min of administration. However, detailed case reports describing the full clinical course and associated changes in monitoring parameters\u2014such as vital signs, capnographic waveforms, and airway pressure\u2014remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We report the case of an 80-year-old man who underwent laparoscopic partial hepatectomy under combined general and epidural anesthesia. Postoperatively, 200\u00a0mg of sugammadex was administered to reverse neuromuscular blockade. Within 2\u00a0min, the ventilator\u2019s high airway pressure alarm was triggered, and capnography showed an obstructive pattern as ventilation became difficult. Suspecting a severe asthma attack, we initiated treatment with 3% sevoflurane for bronchodilation and administered 0.3\u00a0mg of intramuscular adrenaline. A full-body examination revealed a red rash on the upper abdomen and redness with edema of the eyelids, confirming an anaphylactic reaction. Sugammadex-induced anaphylaxis was diagnosed. The systolic blood pressure had transiently dropped to 71 mmHg but improved with a single 0.15\u00a0mg dose of phenylephrine. Extubation was delayed due to marked upper airway edema and an incompletely normalized capnographic pattern of obstruction; the patient was maintained on mechanical ventilation under deep sedation until safe extubation on postoperative day 1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Sugammadex-induced anaphylaxis can occur rapidly following administration. This case highlights the value of continuous electronic monitoring, which enabled documentation of detailed real-time changes in vital signs, capnography, and airway pressure from the onset of bronchospasm to recovery. Given persistent bronchospasm despite adequate oxygenation, mechanical ventilation was continued with the patient intubated and sedated. Such comprehensive monitoring data provide important insights for the early recognition and management of intraoperative anaphylaxis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12871-025-03226-4","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T02:48:31Z","timestamp":1751856511000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anesthesia information system\u2013assisted detection and effective management of sugammadex-induced anaphylaxis: a case report"],"prefix":"10.1186","volume":"25","author":[{"given":"Yuhei","family":"Mae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiyoshi","family":"Sanuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"key":"3226_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.bja.2023.02.018","volume":"131","author":"T Takazawa","year":"2023","unstructured":"Takazawa T, Horiuchi T, Nagumo K, Sugiyama Y, Akune T, Amano Y, et al. The Japanese epidemiologic study for perioperative anaphylaxis, a prospective nationwide study: allergen exposure, epidemiology, and diagnosis of anaphylaxis during general anaesthesia. Br J Anaesth. 2023;131:159\u201369.","journal-title":"Br J Anaesth."},{"key":"3226_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4103\/joacp.JOACP_383_19","volume":"37","author":"B Arslan","year":"2021","unstructured":"Arslan B, Sahin T, Ozdogan H. Sugammadex and anaphylaxis: an analysis of 33 published cases. J Anaesthesiol Clin Pharmacol. 2021;37:153\u20139.","journal-title":"J Anaesthesiol Clin Pharmacol."},{"key":"3226_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.bja.2018.04.014","volume":"121","author":"NJN Harper","year":"2018","unstructured":"Harper NJN, Cook TM, Garcez T, Farmer L, Floss K, Marinho S, et al. Anaesthesia, surgery, and life-threatening allergic reactions: epidemiology and clinical features of perioperative anaphylaxis in the 6th National Audit Project (NAP6). Br J Anaesth. 2018;121:159\u201371.","journal-title":"Br J Anaesth."},{"key":"3226_CR4","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/ALN.0000000000004123","volume":"136","author":"C Erlich","year":"2022","unstructured":"Erlich C, Lamer A, Moussa MD, Martin J, Rogeau S, Tavernier B. End-tidal carbon dioxide for diagnosing anaphylaxis in patients with severe postinduction hypotension. Anesthesiology. 2022;136:472\u201381.","journal-title":"Anesthesiology."},{"key":"3226_CR5","doi-asserted-by":"publisher","first-page":"360","DOI":"10.4103\/joacp.JOACP_573_20","volume":"38","author":"F Zecic","year":"2022","unstructured":"Zecic F, Smar MH, Abbey TC, Pazhempallil A, Korban C. Sugammadex-induced anaphylactic reaction: a systematic review. J Anaesthesiol Clin Pharmacol. 2022;38:360\u201370.","journal-title":"J Anaesthesiol Clin Pharmacol."},{"key":"3226_CR6","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s00540-015-2105-x","volume":"30","author":"T Takazawa","year":"2016","unstructured":"Takazawa T, Mitsuhata H, Mertes PM. Sugammadex and rocuronium-induced anaphylaxis. J Anesth. 2016;30:290\u20137.","journal-title":"J Anesth."},{"key":"3226_CR7","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1111\/anae.12736","volume":"69","author":"A Tsur","year":"2014","unstructured":"Tsur A, Kalansky A. Hypersensitivity associated with sugammadex administration: a systematic review. Anaesthesia. 2014;69:1251\u20137.","journal-title":"Anaesthesia."}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-025-03226-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-025-03226-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-025-03226-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:55:57Z","timestamp":1781610957000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12871-025-03226-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":7,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3226"],"URL":"https:\/\/doi.org\/10.1186\/s12871-025-03226-4","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]},"assertion":[{"value":"22 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this case report was obtained from the institutional review board of our hospital (2024-98). The patient provided informed consent for the described anesthetic management.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and the accompanying data (including images and monitor recordings).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"341"}}